1. A new biological marker in inflammatory bowel disease: Pentraxin 3
   Semih KALYON et al, 2020, Journal of Surgery and Medicine CrossRef
2. The pentraxin family in autoimmune disease
   Yongzhen Li et al, 2023, Clinica Chimica Acta CrossRef
3. Clinical Significance of CD147 in Children with Inflammatory Bowel Disease
   Hongli Wang et al, 2020, BioMed Research International CrossRef
4. Pentraxin 3: A promising therapeutic target for autoimmune diseases
   Qian Wu et al, 2020, Autoimmunity Reviews CrossRef
5. Molecular insight into pentraxin-3: Update advances in innate immunity, inflammation, tissue remodeling, diseases, and drug role
   Hao Zhang et al, 2022, Biomedicine & Pharmacotherapy CrossRef
6. Usefulness of Proguanylin, Pentraxin 3 and S100A12 Serum Concentrations in Diagnosis and Monitoring the Disease Activity in Crohn’s Disease
   Aleksandra Kałużna et al, 2023, Biomolecules CrossRef
7. Therapeutic effects of vitamin D on acetic acid-induced colitis in rats
   Refik Bademci et al, 2020, Acta Cirúrgica Brasileira CrossRef
8. Microparticles Produced by Activated Platelets Carry a Potent and Functionally Active Angiogenic Signal in Subjects with Crohn’s Disease
   Eleonora Gaetani et al, 2018, International Journal of Molecular Sciences CrossRef